Trials / Completed
CompletedNCT03125460
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 424 (actual)
- Sponsor
- Cepheid · Industry
- Sex
- All
- Age
- 40 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Xpert Bladder Cancer Monitor | in vitro diagnostic test for the recurrence of bladder cancer in patients that have been previously diagnosed with bladder cancer |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-02-01
- Completion
- 2019-05-01
- First posted
- 2017-04-24
- Last updated
- 2020-02-07
Locations
17 sites across 3 countries: United States, Canada, Netherlands
Source: ClinicalTrials.gov record NCT03125460. Inclusion in this directory is not an endorsement.